Sensyne Health plc
Get $10 bonus on your first $100 deposit for SSYNF
Get $10 bonus on your first $100 deposit for SSYNF
Sensyne Health plc (SSYNF) Stock Competitors & Peer Comparison
See (SSYNF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SSYNF | $0.00 | -96.08% | 33.3K | -0.00 | -$0.27 | N/A |
| PMCUF | $92.84 | +11.86% | 9.7B | 59.90 | $1.55 | +0.46% |
| MTHRF | $11.00 | +0.00% | 7.5B | 26.19 | $0.42 | +1.19% |
| MTHRY | $5.28 | +2.52% | 7.1B | 25.00 | $0.21 | N/A |
| PANHF | $1.55 | -12.22% | 3.3B | 51.50 | $0.03 | N/A |
| PIAHY | $4.40 | +0.00% | 2.3B | 88.00 | $0.05 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +0.17% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| CRWRF | $24.20 | +0.00% | 850.7M | 44.00 | $0.55 | +1.84% |
| SMSZF | $8.56 | +0.00% | 702.6M | 17.83 | $0.48 | +2.41% |
Stock Comparison
SSYNF vs PMCUF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PMCUF has a market cap of 9.7B. Regarding current trading prices, SSYNF is priced at $0.00, while PMCUF trades at $92.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PMCUF's P/E ratio is 59.90. In terms of profitability, SSYNF's ROE is N/A, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, SSYNF is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check PMCUF's competition here
SSYNF vs MTHRF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MTHRF has a market cap of 7.5B. Regarding current trading prices, SSYNF is priced at $0.00, while MTHRF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MTHRF's P/E ratio is 26.19. In terms of profitability, SSYNF's ROE is N/A, compared to MTHRF's ROE of +0.18%. Regarding short-term risk, SSYNF and MTHRF have similar daily volatility (0.00).Check MTHRF's competition here
SSYNF vs MTHRY Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MTHRY has a market cap of 7.1B. Regarding current trading prices, SSYNF is priced at $0.00, while MTHRY trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MTHRY's P/E ratio is 25.00. In terms of profitability, SSYNF's ROE is N/A, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, SSYNF is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check MTHRY's competition here
SSYNF vs PANHF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PANHF has a market cap of 3.3B. Regarding current trading prices, SSYNF is priced at $0.00, while PANHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PANHF's P/E ratio is 51.50. In terms of profitability, SSYNF's ROE is N/A, compared to PANHF's ROE of +0.04%. Regarding short-term risk, SSYNF and PANHF have similar daily volatility (0.00).Check PANHF's competition here
SSYNF vs PIAHY Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PIAHY has a market cap of 2.3B. Regarding current trading prices, SSYNF is priced at $0.00, while PIAHY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PIAHY's P/E ratio is 88.00. In terms of profitability, SSYNF's ROE is N/A, compared to PIAHY's ROE of +0.04%. Regarding short-term risk, SSYNF and PIAHY have similar daily volatility (0.00).Check PIAHY's competition here
SSYNF vs CMPVF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, SSYNF is priced at $0.00, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, SSYNF's ROE is N/A, compared to CMPVF's ROE of +0.01%. Regarding short-term risk, SSYNF is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check CMPVF's competition here
SSYNF vs CMPUY Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, SSYNF is priced at $0.00, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, SSYNF's ROE is N/A, compared to CMPUY's ROE of +0.01%. Regarding short-term risk, SSYNF and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
SSYNF vs CRWRF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CRWRF has a market cap of 850.7M. Regarding current trading prices, SSYNF is priced at $0.00, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, SSYNF's ROE is N/A, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, SSYNF is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check CRWRF's competition here
SSYNF vs SMSZF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, SSYNF is priced at $0.00, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, SSYNF's ROE is N/A, compared to SMSZF's ROE of +0.15%. Regarding short-term risk, SSYNF and SMSZF have similar daily volatility (0.00).Check SMSZF's competition here
SSYNF vs RSLBF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, RSLBF has a market cap of 699.6M. Regarding current trading prices, SSYNF is priced at $0.00, while RSLBF trades at $19.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas RSLBF's P/E ratio is 27.56. In terms of profitability, SSYNF's ROE is N/A, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, SSYNF and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
SSYNF vs VHIBF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, VHIBF has a market cap of 319.3M. Regarding current trading prices, SSYNF is priced at $0.00, while VHIBF trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas VHIBF's P/E ratio is 72.14. In terms of profitability, SSYNF's ROE is N/A, compared to VHIBF's ROE of +0.03%. Regarding short-term risk, SSYNF and VHIBF have similar daily volatility (0.00).Check VHIBF's competition here
SSYNF vs SMDCF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, SSYNF is priced at $0.00, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, SSYNF's ROE is N/A, compared to SMDCF's ROE of N/A. Regarding short-term risk, SSYNF and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
SSYNF vs COGZF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, COGZF has a market cap of 265M. Regarding current trading prices, SSYNF is priced at $0.00, while COGZF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas COGZF's P/E ratio is 25.83. In terms of profitability, SSYNF's ROE is N/A, compared to COGZF's ROE of +0.29%. Regarding short-term risk, SSYNF and COGZF have similar daily volatility (0.00).Check COGZF's competition here
SSYNF vs KSIOF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, KSIOF has a market cap of 259.6M. Regarding current trading prices, SSYNF is priced at $0.00, while KSIOF trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas KSIOF's P/E ratio is -271.00. In terms of profitability, SSYNF's ROE is N/A, compared to KSIOF's ROE of -0.04%. Regarding short-term risk, SSYNF is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check KSIOF's competition here
SSYNF vs DLHTF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, SSYNF is priced at $0.00, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, SSYNF's ROE is N/A, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, SSYNF and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
SSYNF vs VPAHF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, SSYNF is priced at $0.00, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, SSYNF's ROE is N/A, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, SSYNF and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
SSYNF vs ACMLF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ACMLF has a market cap of 149.3M. Regarding current trading prices, SSYNF is priced at $0.00, while ACMLF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ACMLF's P/E ratio is 43.70. In terms of profitability, SSYNF's ROE is N/A, compared to ACMLF's ROE of +0.20%. Regarding short-term risk, SSYNF and ACMLF have similar daily volatility (0.00).Check ACMLF's competition here
SSYNF vs SUSRF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, SSYNF is priced at $0.00, while SUSRF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, SSYNF's ROE is N/A, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, SSYNF and SUSRF have similar daily volatility (0.00).Check SUSRF's competition here
SSYNF vs ONVVF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, SSYNF is priced at $0.00, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, SSYNF's ROE is N/A, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, SSYNF and ONVVF have similar daily volatility (0.00).Check ONVVF's competition here
SSYNF vs CSAMF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, SSYNF is priced at $0.00, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, SSYNF's ROE is N/A, compared to CSAMF's ROE of -0.85%. Regarding short-term risk, SSYNF and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
SSYNF vs HITC Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, SSYNF is priced at $0.00, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas HITC's P/E ratio is -14.75. In terms of profitability, SSYNF's ROE is N/A, compared to HITC's ROE of -0.79%. Regarding short-term risk, SSYNF is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check HITC's competition here
SSYNF vs MDPEF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, SSYNF is priced at $0.00, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, SSYNF's ROE is N/A, compared to MDPEF's ROE of N/A. Regarding short-term risk, SSYNF and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here
SSYNF vs TREIF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, SSYNF is priced at $0.00, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas TREIF's P/E ratio is -3.46. In terms of profitability, SSYNF's ROE is N/A, compared to TREIF's ROE of -1.90%. Regarding short-term risk, SSYNF is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check TREIF's competition here
SSYNF vs EMOR Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, EMOR has a market cap of 30.6M. Regarding current trading prices, SSYNF is priced at $0.00, while EMOR trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas EMOR's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to EMOR's ROE of +0.06%. Regarding short-term risk, SSYNF is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check EMOR's competition here
SSYNF vs VASO Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, VASO has a market cap of 28.8M. Regarding current trading prices, SSYNF is priced at $0.00, while VASO trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas VASO's P/E ratio is 16.37. In terms of profitability, SSYNF's ROE is N/A, compared to VASO's ROE of -0.15%. Regarding short-term risk, SSYNF is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check VASO's competition here
SSYNF vs RTNXF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, SSYNF is priced at $0.00, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, SSYNF's ROE is N/A, compared to RTNXF's ROE of -6.31%. Regarding short-term risk, SSYNF is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check RTNXF's competition here
SSYNF vs HDSLF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, SSYNF is priced at $0.00, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, SSYNF's ROE is N/A, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, SSYNF is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check HDSLF's competition here
SSYNF vs DGNOF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, DGNOF has a market cap of 18.4M. Regarding current trading prices, SSYNF is priced at $0.00, while DGNOF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas DGNOF's P/E ratio is -4.52. In terms of profitability, SSYNF's ROE is N/A, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, SSYNF is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check DGNOF's competition here
SSYNF vs THKKF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, SSYNF is priced at $0.00, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas THKKF's P/E ratio is -1.51. In terms of profitability, SSYNF's ROE is N/A, compared to THKKF's ROE of -0.61%. Regarding short-term risk, SSYNF and THKKF have similar daily volatility (0.00).Check THKKF's competition here
SSYNF vs CRVW Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CRVW has a market cap of 17.5M. Regarding current trading prices, SSYNF is priced at $0.00, while CRVW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CRVW's P/E ratio is -3.00. In terms of profitability, SSYNF's ROE is N/A, compared to CRVW's ROE of +0.17%. Regarding short-term risk, SSYNF and CRVW have similar daily volatility (0.00).Check CRVW's competition here
SSYNF vs MNNDF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, SSYNF is priced at $0.00, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, SSYNF's ROE is N/A, compared to MNNDF's ROE of N/A. Regarding short-term risk, SSYNF is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check MNNDF's competition here
SSYNF vs WLSS Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, WLSS has a market cap of 12.7M. Regarding current trading prices, SSYNF is priced at $0.00, while WLSS trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas WLSS's P/E ratio is -460.00. In terms of profitability, SSYNF's ROE is N/A, compared to WLSS's ROE of +0.33%. Regarding short-term risk, SSYNF is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check WLSS's competition here
SSYNF vs PBSV Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PBSV has a market cap of 11.5M. Regarding current trading prices, SSYNF is priced at $0.00, while PBSV trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PBSV's P/E ratio is -50.00. In terms of profitability, SSYNF's ROE is N/A, compared to PBSV's ROE of -0.00%. Regarding short-term risk, SSYNF is less volatile compared to PBSV. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check PBSV's competition here
SSYNF vs BRGX Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, BRGX has a market cap of 10.9M. Regarding current trading prices, SSYNF is priced at $0.00, while BRGX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas BRGX's P/E ratio is -1.14. In terms of profitability, SSYNF's ROE is N/A, compared to BRGX's ROE of +5.32%. Regarding short-term risk, SSYNF and BRGX have similar daily volatility (0.00).Check BRGX's competition here
SSYNF vs CDXFF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, SSYNF is priced at $0.00, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, SSYNF's ROE is N/A, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, SSYNF and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here
SSYNF vs CMHSF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CMHSF has a market cap of 9.5M. Regarding current trading prices, SSYNF is priced at $0.00, while CMHSF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CMHSF's P/E ratio is -3.53. In terms of profitability, SSYNF's ROE is N/A, compared to CMHSF's ROE of +0.28%. Regarding short-term risk, SSYNF and CMHSF have similar daily volatility (0.00).Check CMHSF's competition here
SSYNF vs HBCNF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, SSYNF is priced at $0.00, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, SSYNF's ROE is N/A, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, SSYNF is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check HBCNF's competition here
SSYNF vs CMPD Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CMPD has a market cap of 8.3M. Regarding current trading prices, SSYNF is priced at $0.00, while CMPD trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CMPD's P/E ratio is -14.22. In terms of profitability, SSYNF's ROE is N/A, compared to CMPD's ROE of -0.04%. Regarding short-term risk, SSYNF and CMPD have similar daily volatility (0.00).Check CMPD's competition here
SSYNF vs SPLTF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, SSYNF is priced at $0.00, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, SSYNF's ROE is N/A, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, SSYNF and SPLTF have similar daily volatility (0.00).Check SPLTF's competition here
SSYNF vs VYND Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, SSYNF is priced at $0.00, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas VYND's P/E ratio is -43.00. In terms of profitability, SSYNF's ROE is N/A, compared to VYND's ROE of +0.81%. Regarding short-term risk, SSYNF and VYND have similar daily volatility (0.00).Check VYND's competition here
SSYNF vs CRBKF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, SSYNF is priced at $0.00, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, SSYNF's ROE is N/A, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, SSYNF and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
SSYNF vs DOCRF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, SSYNF is priced at $0.00, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, SSYNF's ROE is N/A, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, SSYNF and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
SSYNF vs UDOCF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, UDOCF has a market cap of 6.1M. Regarding current trading prices, SSYNF is priced at $0.00, while UDOCF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas UDOCF's P/E ratio is -2.37. In terms of profitability, SSYNF's ROE is N/A, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, SSYNF is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check UDOCF's competition here
SSYNF vs IQAIF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, SSYNF is priced at $0.00, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas IQAIF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, SSYNF is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check IQAIF's competition here
SSYNF vs AIMLF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, AIMLF has a market cap of 4.4M. Regarding current trading prices, SSYNF is priced at $0.00, while AIMLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas AIMLF's P/E ratio is -1.32. In terms of profitability, SSYNF's ROE is N/A, compared to AIMLF's ROE of -5.05%. Regarding short-term risk, SSYNF is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check AIMLF's competition here
SSYNF vs CBDS Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, SSYNF is priced at $0.00, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CBDS's P/E ratio is -1.49. In terms of profitability, SSYNF's ROE is N/A, compared to CBDS's ROE of +0.68%. Regarding short-term risk, SSYNF is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check CBDS's competition here
SSYNF vs RQHTF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, SSYNF is priced at $0.00, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, SSYNF's ROE is N/A, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, SSYNF and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
SSYNF vs NDATF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, NDATF has a market cap of 2.5M. Regarding current trading prices, SSYNF is priced at $0.00, while NDATF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas NDATF's P/E ratio is -6.00. In terms of profitability, SSYNF's ROE is N/A, compared to NDATF's ROE of -0.64%. Regarding short-term risk, SSYNF and NDATF have similar daily volatility (0.00).Check NDATF's competition here
SSYNF vs RYAHF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, SSYNF is priced at $0.00, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, SSYNF's ROE is N/A, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, SSYNF and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here
SSYNF vs RSLT Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, RSLT has a market cap of 2.2M. Regarding current trading prices, SSYNF is priced at $0.00, while RSLT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas RSLT's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to RSLT's ROE of N/A. Regarding short-term risk, SSYNF and RSLT have similar daily volatility (0.00).Check RSLT's competition here
SSYNF vs EBYH Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, EBYH has a market cap of 1.9M. Regarding current trading prices, SSYNF is priced at $0.00, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas EBYH's P/E ratio is -5.42. In terms of profitability, SSYNF's ROE is N/A, compared to EBYH's ROE of +0.09%. Regarding short-term risk, SSYNF is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check EBYH's competition here
SSYNF vs MDBIF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, SSYNF is priced at $0.00, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MDBIF's P/E ratio is -0.25. In terms of profitability, SSYNF's ROE is N/A, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, SSYNF and MDBIF have similar daily volatility (0.00).Check MDBIF's competition here
SSYNF vs CSOC Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CSOC has a market cap of 1.4M. Regarding current trading prices, SSYNF is priced at $0.00, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CSOC's P/E ratio is 0.17. In terms of profitability, SSYNF's ROE is N/A, compared to CSOC's ROE of -3.87%. Regarding short-term risk, SSYNF is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check CSOC's competition here
SSYNF vs DSOL Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, DSOL has a market cap of 1.2M. Regarding current trading prices, SSYNF is priced at $0.00, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas DSOL's P/E ratio is -0.04. In terms of profitability, SSYNF's ROE is N/A, compared to DSOL's ROE of +0.03%. Regarding short-term risk, SSYNF and DSOL have similar daily volatility (0.00).Check DSOL's competition here
SSYNF vs MDXL Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MDXL has a market cap of 1.2M. Regarding current trading prices, SSYNF is priced at $0.00, while MDXL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MDXL's P/E ratio is -0.28. In terms of profitability, SSYNF's ROE is N/A, compared to MDXL's ROE of +0.90%. Regarding short-term risk, SSYNF and MDXL have similar daily volatility (0.00).Check MDXL's competition here
SSYNF vs MITI Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MITI has a market cap of 1M. Regarding current trading prices, SSYNF is priced at $0.00, while MITI trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MITI's P/E ratio is -0.13. In terms of profitability, SSYNF's ROE is N/A, compared to MITI's ROE of +0.17%. Regarding short-term risk, SSYNF is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check MITI's competition here
SSYNF vs EKGGF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, SSYNF is priced at $0.00, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas EKGGF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to EKGGF's ROE of +1.04%. Regarding short-term risk, SSYNF and EKGGF have similar daily volatility (0.00).Check EKGGF's competition here
SSYNF vs EVAHF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, EVAHF has a market cap of 662.2K. Regarding current trading prices, SSYNF is priced at $0.00, while EVAHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas EVAHF's P/E ratio is -0.27. In terms of profitability, SSYNF's ROE is N/A, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, SSYNF and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here
SSYNF vs DTRK Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, DTRK has a market cap of 549.5K. Regarding current trading prices, SSYNF is priced at $0.00, while DTRK trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas DTRK's P/E ratio is -4.78. In terms of profitability, SSYNF's ROE is N/A, compared to DTRK's ROE of +3.54%. Regarding short-term risk, SSYNF is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check DTRK's competition here
SSYNF vs MDNWF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, SSYNF is priced at $0.00, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, SSYNF's ROE is N/A, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, SSYNF and MDNWF have similar daily volatility (0.00).Check MDNWF's competition here
SSYNF vs USPS Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, USPS has a market cap of 455.1K. Regarding current trading prices, SSYNF is priced at $0.00, while USPS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas USPS's P/E ratio is -2.87. In terms of profitability, SSYNF's ROE is N/A, compared to USPS's ROE of +0.62%. Regarding short-term risk, SSYNF and USPS have similar daily volatility (0.00).Check USPS's competition here
SSYNF vs PPJE Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PPJE has a market cap of 445.2K. Regarding current trading prices, SSYNF is priced at $0.00, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PPJE's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to PPJE's ROE of -0.00%. Regarding short-term risk, SSYNF and PPJE have similar daily volatility (0.00).Check PPJE's competition here
SSYNF vs CTVEF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, SSYNF is priced at $0.00, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, SSYNF's ROE is N/A, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, SSYNF and CTVEF have similar daily volatility (0.00).Check CTVEF's competition here
SSYNF vs LVCE Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, LVCE has a market cap of 381.9K. Regarding current trading prices, SSYNF is priced at $0.00, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas LVCE's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to LVCE's ROE of N/A. Regarding short-term risk, SSYNF and LVCE have similar daily volatility (0.00).Check LVCE's competition here
SSYNF vs ACHKF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, SSYNF is priced at $0.00, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, SSYNF's ROE is N/A, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, SSYNF and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
SSYNF vs NHIQ Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, SSYNF is priced at $0.00, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, SSYNF's ROE is N/A, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, SSYNF is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check NHIQ's competition here
SSYNF vs MDRM Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MDRM has a market cap of 255.1K. Regarding current trading prices, SSYNF is priced at $0.00, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MDRM's P/E ratio is -0.20. In terms of profitability, SSYNF's ROE is N/A, compared to MDRM's ROE of +0.42%. Regarding short-term risk, SSYNF and MDRM have similar daily volatility (0.00).Check MDRM's competition here
SSYNF vs ALDNF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, SSYNF is priced at $0.00, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ALDNF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, SSYNF and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
SSYNF vs TSTTF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, SSYNF is priced at $0.00, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, SSYNF's ROE is N/A, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, SSYNF and TSTTF have similar daily volatility (0.00).Check TSTTF's competition here
SSYNF vs EMYSF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, SSYNF is priced at $0.00, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas EMYSF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, SSYNF and EMYSF have similar daily volatility (0.00).Check EMYSF's competition here
SSYNF vs RVRC Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, RVRC has a market cap of 130.8K. Regarding current trading prices, SSYNF is priced at $0.00, while RVRC trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas RVRC's P/E ratio is -0.35. In terms of profitability, SSYNF's ROE is N/A, compared to RVRC's ROE of +0.07%. Regarding short-term risk, SSYNF and RVRC have similar daily volatility (0.00).Check RVRC's competition here
SSYNF vs NEWUF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, SSYNF is priced at $0.00, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, SSYNF's ROE is N/A, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, SSYNF and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
SSYNF vs PASO Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, SSYNF is priced at $0.00, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PASO's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to PASO's ROE of +6.20%. Regarding short-term risk, SSYNF and PASO have similar daily volatility (0.00).Check PASO's competition here
SSYNF vs LFCOF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, LFCOF has a market cap of 71.6K. Regarding current trading prices, SSYNF is priced at $0.00, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, SSYNF's ROE is N/A, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, SSYNF and LFCOF have similar daily volatility (0.00).Check LFCOF's competition here
SSYNF vs REFG Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, SSYNF is priced at $0.00, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas REFG's P/E ratio is -0.01. In terms of profitability, SSYNF's ROE is N/A, compared to REFG's ROE of +0.01%. Regarding short-term risk, SSYNF and REFG have similar daily volatility (0.00).Check REFG's competition here
SSYNF vs SOFE Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, SSYNF is priced at $0.00, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas SOFE's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to SOFE's ROE of +0.52%. Regarding short-term risk, SSYNF and SOFE have similar daily volatility (0.00).Check SOFE's competition here
SSYNF vs HDVY Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, SSYNF is priced at $0.00, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas HDVY's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to HDVY's ROE of +15.89%. Regarding short-term risk, SSYNF and HDVY have similar daily volatility (0.00).Check HDVY's competition here
SSYNF vs IGRW Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, SSYNF is priced at $0.00, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas IGRW's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to IGRW's ROE of -2.28%. Regarding short-term risk, SSYNF and IGRW have similar daily volatility (0.00).Check IGRW's competition here
SSYNF vs WMGR Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, SSYNF is priced at $0.00, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas WMGR's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to WMGR's ROE of +0.53%. Regarding short-term risk, SSYNF and WMGR have similar daily volatility (0.00).Check WMGR's competition here
SSYNF vs TTBLF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, SSYNF is priced at $0.00, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, SSYNF's ROE is N/A, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, SSYNF is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check TTBLF's competition here
SSYNF vs FDBH Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, FDBH has a market cap of 25K. Regarding current trading prices, SSYNF is priced at $0.00, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas FDBH's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to FDBH's ROE of +0.32%. Regarding short-term risk, SSYNF and FDBH have similar daily volatility (0.00).Check FDBH's competition here
SSYNF vs NMXS Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, NMXS has a market cap of 18.8K. Regarding current trading prices, SSYNF is priced at $0.00, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas NMXS's P/E ratio is -0.05. In terms of profitability, SSYNF's ROE is N/A, compared to NMXS's ROE of -2.50%. Regarding short-term risk, SSYNF and NMXS have similar daily volatility (0.00).Check NMXS's competition here
SSYNF vs EWLL Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, EWLL has a market cap of 18.5K. Regarding current trading prices, SSYNF is priced at $0.00, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas EWLL's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to EWLL's ROE of +0.13%. Regarding short-term risk, SSYNF and EWLL have similar daily volatility (0.00).Check EWLL's competition here
SSYNF vs NHEL Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, SSYNF is priced at $0.00, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas NHEL's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to NHEL's ROE of +7.36%. Regarding short-term risk, SSYNF and NHEL have similar daily volatility (0.00).Check NHEL's competition here
SSYNF vs ORHB Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ORHB has a market cap of 13.8K. Regarding current trading prices, SSYNF is priced at $0.00, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ORHB's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to ORHB's ROE of +1.70%. Regarding short-term risk, SSYNF and ORHB have similar daily volatility (0.00).Check ORHB's competition here
SSYNF vs BNVIF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, SSYNF is priced at $0.00, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas BNVIF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, SSYNF and BNVIF have similar daily volatility (0.00).Check BNVIF's competition here
SSYNF vs HLTT Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, SSYNF is priced at $0.00, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas HLTT's P/E ratio is -0.00. In terms of profitability, SSYNF's ROE is N/A, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, SSYNF and HLTT have similar daily volatility (0.00).Check HLTT's competition here
SSYNF vs CGNSF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, SSYNF is priced at $0.00, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CGNSF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, SSYNF and CGNSF have similar daily volatility (0.00).Check CGNSF's competition here
SSYNF vs MOSTQ Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, SSYNF is priced at $0.00, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, SSYNF's ROE is N/A, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, SSYNF and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
SSYNF vs ACNV Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, SSYNF is priced at $0.00, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ACNV's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to ACNV's ROE of +0.85%. Regarding short-term risk, SSYNF and ACNV have similar daily volatility (0.00).Check ACNV's competition here
SSYNF vs AHGIF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, SSYNF is priced at $0.00, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas AHGIF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, SSYNF and AHGIF have similar daily volatility (0.00).Check AHGIF's competition here
SSYNF vs BBLNF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, SSYNF is priced at $0.00, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas BBLNF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, SSYNF and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
SSYNF vs ICCO Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, SSYNF is priced at $0.00, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ICCO's P/E ratio is -0.01. In terms of profitability, SSYNF's ROE is N/A, compared to ICCO's ROE of +0.17%. Regarding short-term risk, SSYNF and ICCO have similar daily volatility (0.00).Check ICCO's competition here
SSYNF vs HSCHF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, HSCHF has a market cap of 1.3K. Regarding current trading prices, SSYNF is priced at $0.00, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas HSCHF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, SSYNF and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here
SSYNF vs PCYS Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, SSYNF is priced at $0.00, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas PCYS's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to PCYS's ROE of -2.71%. Regarding short-term risk, SSYNF is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for SSYNF.Check PCYS's competition here
SSYNF vs CNONF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, SSYNF is priced at $0.00, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas CNONF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to CNONF's ROE of +1.60%. Regarding short-term risk, SSYNF and CNONF have similar daily volatility (0.00).Check CNONF's competition here
SSYNF vs OLMM Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, SSYNF is priced at $0.00, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas OLMM's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to OLMM's ROE of +4.54%. Regarding short-term risk, SSYNF and OLMM have similar daily volatility (0.00).Check OLMM's competition here
SSYNF vs ETAOF Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, SSYNF is priced at $0.00, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas ETAOF's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, SSYNF and ETAOF have similar daily volatility (0.00).Check ETAOF's competition here
SSYNF vs LGBI Comparison April 2026
SSYNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSYNF stands at 33.3K. In comparison, LGBI has a market cap of 50. Regarding current trading prices, SSYNF is priced at $0.00, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSYNF currently has a P/E ratio of -0.00, whereas LGBI's P/E ratio is N/A. In terms of profitability, SSYNF's ROE is N/A, compared to LGBI's ROE of +0.00%. Regarding short-term risk, SSYNF and LGBI have similar daily volatility (0.00).Check LGBI's competition here